Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells

Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells

Brain tumor glioblastoma is one of the worst types of cancer. The blood–brain barrier prevents drugs from reaching brain cells and shields glioblastoma from treatment. The creation of nanocarriers to improve drug delivery and internalization effectiveness may be the solution to this issue. In this p...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Albina Y. Ziganshina, Elina E. Mansurova, Alexandra D. Voloshina, Anna P. Lyubina, Syumbelya K. Amerhanova, Marina M. Shulaeva, Irek R. Nizameev, Marsil K. Kadirov, Leysan R. Bakhtiozina, Vyacheslav E. Semenov, Igor S. Antipin
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: MDPI AG 2023-01-01
Sraith:Molecules
Ábhair:
glioblastoma
doxorubicin
nanocarrier
uracil
thymine
diallyl disulfide
Rochtain ar líne:https://www.mdpi.com/1420-3049/28/2/551

Ar líne

https://www.mdpi.com/1420-3049/28/2/551

Míreanna comhchosúla